Table 3.
Age < 65 years | Age 65+ years | ||||||
---|---|---|---|---|---|---|---|
Racial and ethnic groups | Total | Fatal cases (%) | HR (95% CI)a | Total | Fatal cases (%) | HR (95% CI)a | P-heterogeneity |
White | 576 | 331 (57.5%) | 1.00 (Ref) | 277 | 227 (81.9%) | 1.00 (Ref) | 0.33 |
Black | 82 | 44 (53.7%) | 0.89 (0.63–1.25) | 38 | 30 (78.9%) | 1.45 (0.93–2.25) | |
Asian | 104 | 51 (49.0%) | 0.67 (0.49–0.92) | 30 | 22 (73.3%) | 0.98 (0.60–1.58) | |
Pacific Islander | 45 | 19 (42.2%) | 1.11 (0.67–1.81) | 13 | 11 (84.6%) | 1.14 (0.58–2.25) | |
Hispanic | 55 | 27 (49.1%) | 0.79 (0.52–1.20) | 10 | 9 (90.0%) | 0.94 (0.45–1.99) |
CI confidence interval, HR hazard ratio.
aAdjusted for histology [serous (reference), endometrioid, clear cell, mucinous, not otherwise specified [NOS], other], stage [local (reference), regional, distant, missing] and year of diagnosis (continuous); age at diagnosis (continuous) was modelled as a strata term.
Bold values indicate that the association is statistically significant.